JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.12 Cr | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹4.12 Cr |
Mar2024 | ₹2.98 Cr |
Mar2023 | ₹3.24 Cr |
Mar2022 | ₹3.92 Cr |
Mar2021 | ₹3.99 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4.12 Cr | 38.12 | |
Mar2024 | ₹2.98 Cr | -7.82 | |
Mar2023 | ₹3.24 Cr | -17.36 | |
Mar2022 | ₹3.92 Cr | -1.81 | |
Mar2021 | ₹3.99 Cr | - |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹612.8 Cr | 5.7% | 21.8% | 55% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 5.7% |
21.8% |
55% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses